On clinical trials with a high placebo response rate

Area of Science:

• Clinical trial methodology
• Biostatistics
• Pharmacometrics

Background:

• Standard randomized placebo-controlled trials often fail due to high placebo response rates, leading to underestimated treatment effects.
• Sequential parallel enrichment designs aim to improve trial efficiency by identifying non-responders for re-randomization.

Purpose of the Study:

• To introduce the concept of an adjusted treatment effect for sequential parallel enrichment designs.
• To address the underestimation of treatment effects and improve benefit/risk analysis and dosage recommendations.

Main Methods:

• Proposes an adjusted treatment effect derived from the first period's apparent effect, modified by second-period information.
• The adjustment incorporates a consistency condition to account for high placebo response rates.

Main Results:

• The proposed adjusted treatment effect provides a more accurate assessment of the true treatment effect.
• This method compensates for the bias introduced by high placebo response rates.

Conclusions:

• The adjusted treatment effect is crucial for accurate benefit/risk assessment and appropriate dosage recommendations in clinical trials.
• Utilizing this adjusted effect enhances the reliability of clinical trial outcomes and decision-making.